IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10201599 B1

PDFFull Text
Date of Patent:
Feb. 12, 2019

Filed:

Aug. 30, 2016

[object object]

Applicant:

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO (US);

Inventors:

Jeremy Kroll, Urbandale, IA (US);

Mike Roof, Ames, IA (US);

Assignee:

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO (US);

Attorney:

Judy Jarecki-Black

Primary Examiner:

Gary B Nickol

Assistant Examiner:

Lakia J Jackson-Tongue

Int. Cl.
CPC ...
A61K 39/02 (2006.01); A61K 45/00 (2006.01); A61K 47/00 (2006.01); A61K 39/116 (2006.01); A61K 39/00 (2006.01); A61K 39/38 (2006.01); A61K 39/112 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 39/39 (2006.01); A61K 35/74 (2015.01); A61K 39/295 (2006.01);
U.S. Cl.
CPC ...
A61K 39/105 (2013.01); A61K 39/0241 (2013.01); A61K 39/0275 (2013.01); A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 35/74 (2013.01); A61K 39/295 (2013.01); A61K 39/39 (2013.01); A61K 2039/521 (2013.01); A61K 2039/522 (2013.01); A61K 2039/525 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/70 (2013.01); C12N 2750/10034 (2013.01); Y02A 50/482 (2018.01); Y10S 424/825 (2013.01);
Abstract

The present invention provides combination vaccines that comprise an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine. Moreover, the present invention also relates to a kit that comprises an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine.

Find Patent Forward Citations

Loading…